Quality of Life in Patients With Allergic Rhinitis: Clinical Trial With Bilastine or Loratadine
Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to verify whether there were differences in health-related
quality of life of patients with allergic rhinitis treated with bilastine 20 mg compared to
those treated with loratadine 10 mg.